ABSTRACT
We isolated cDNAs encoding a mouse interleukin 10 receptor (mIL-lOR) from mouse mast cell and macrophage cell lines. The two cDNAs are substantially identical and express an 10-kDa polypeptide in COS7 cells, which binds mIL-10 specifically. A mouse pro-B-cell line (Ba/F3) expressing transfected recombinant mIL-lOR binds IL-10 with high affinity (=70 pM) and proliferates in response to mIL-10. mIL-lOR is structurally related to interferon receptors (IFNRs). Since IL-10 inhibits macrophage activation by IFN-y, a possible implication of this relationship is interaction of IL-1OR and IFN-yR or their signaling pathways.
Interleukin 10 (IL-10) is a cytokine produced by activated T cells, B cells, keratinocytes, and monocytes/macrophages (1) . Mouse and human IL-10 (mIL-10, hIL-10) inhibit cytokine synthesis by activated T cells (2) (3) (4) , natural killer cells (5) , and monocytes/macrophages (6) (7) (8) and block the ability of macrophages to act as antigen-presenting (3, 4) or costimulatory (5) cells. Like other cytokines, IL-10 has multiple activities, including costimulation of proliferation and differentiation of human B cells (9) , mouse thymocytes, T cells (10) (11) (12) , and mast cells (13) , up-regulation of class II major histocompatibility complex (MHC) expression on mouse B cells (14) , and sustaining viability of mouse mast cell lines and mouse B cells in vitro (14, 15) . IL-10 is homologous to an Epstein-Barr virus gene, BCRF1 (15, 16) . BCRF1 (viral IL-10, vIL-10) exhibits some but not all of the activities of IL-10 on mouse and human cells (1) . The activities of are likely mediated via cell surface receptors (IL-lORs); here we describe detection of mIL-lOR and report the structure and expression of mIL-lOR cDNA clones. § Recombinant mIL-lOR expressed in the IL-3-dependent mouse pro-B-cell line Ba/F3 binds IL-10 with high affinity and transduces a growth signal in response to mIL-10. We found unexpectedly that mIL-lOR is a member of the class II [interferon receptor (IFNR)-like] subgroup of the cytokine receptor (CR) family.
MATERIALS AND METHODS
Cell Lines and Antibodies. MC/9 and Ba/F3 cells have been described (13, 17) . J774 cells were from the American Type Culture Collection. Cell lines used in RNA blot analysis were from A. Miyajima, L. Lanier, D. Rennick, and G. Zurawski (DNAX). Anti-mIL-10 (2A5) and isotype control (GL113) monoclonal antibodies (mAbs) were from J. Abrams and J. Silver. Anti-FLAG mAbs Ml and M2 were purchased from IBI-Kodak. Streptavidin-phycoerythrin (SA-PE) was from Becton Dickinson.
Structure and Expression of FLAG-mIL-10. A leader sequence and FLAG (18) peptide sequence were fused to the mIL-10 coding region (1, 16) (16) .
Detection of mIL-lOR. Fluorescence-activated cell sorting (FACS). Cells were washed twice with FACS buffer (Hanks' balanced salt solution/3% fetal calf serum/0.01% NaN3) and incubated with 3-30 nM FLAG-mIL-10 on ice for 1 hr. Cells were pelleted and subjected to cross-linking with 0.2 mM bis(sulfosuccinimidyl) suberate (BS3; Pierce) as described (20) and then washed once and resuspended in FACS buffer containing 20 absence of 150 nM hIL-10 (T. Nagabhushan, ScheringPlough) for 4 hr at 4°C in RPMI 1640 medium/2% bovine serum albumin/0.02% sodium azide and then pelleted through a mixture ofphthalate oils as described (21) (22) (23) . The cell pellet and supernatant were assessed for bound and free 125I cpm, respectively. Nonspecific binding cpm in samples containing unlabeled hIL-10 were subtracted to obtain specific binding cpm. Values for Kd and receptor number were obtained by Scatchard analysis as described (21) . SDS/PAGE. Cells (5-15 x 107 MC/9, after the fifth cycle of sorting, or 1-4 x 106 transfected COS7) were incubated with 35S-labeled FLAG-mIL-10 (35S-FLAG-mIL-10) ( anti-mouse IgG. The Pansorbin was removed by centrifugation and the supernatant was subjected to immunoprecipitation with 20 ug of anti-FLAG mAb M2 per ml followed by fresh rabbit anti-mouse IgG/Pansorbin. After several washes, the Pansorbin was boiled for 3 min in reducing sample buffer, and the eluate was analyzed by 7.5% SDS/ PAGE and autoradiography.
cDNA Libraries. cDNA libraries were prepared using the SuperScript plasmid system (BRL), but using BstXI instead of Sal I adaptors (Invitrogen). cDNA was size-selected on Chromaspin-1000 (Clontech) and ligated into Not I-BstXIdigested pJFE14 (24) . The MC/9-b2 and J774-al cDNA libraries contained 5.5 x 106 and 2 x 106 independent clones, respectively.
Isolation of mIL-lOR cDNA Clones. mIL-lOR cDNA clones were isolated by incubating COS7 cells transfected with cDNA library DNA with FLAG-mIL-10 followed by crosslinking and selection (panning) of COS7 cells expressing mIL-lOR on plates coated with anti-FLAG mAb (25, 26) . After three or four cycles of transfection and panning, the recovered plasmid DNA was highly enriched for mIL-lOR cDNAs. Sequence data were obtained as described (15) and analyzed using software from IntelliGenetics.
Analysis of mIL-lOR mRNA Expression. mIL-lOR mRNA expression was detected by RNA blot (15) . mIL-lOR RNA was also detected in ethidium bromide-stained gels as an -500-bp amplified fragment by PCR. PCR primers were 5 '-AGGCAGAGGCAGCAGGCCCAGCAGAATGCT-3' (sense) and 5'-TGGAGCCTGGCTAGCTGGTCACAGTAG-GTCT-3' (antisense).
Expression of mIL-lOR in Transfected Ba/F3 Cells. The mIL-lOR cDNA pMR29 was cotransfected into Ba/F3 cells (17) with a plasmid containing a gene for neomycin resistance. Transfectants were selected in 1 mg ofG418 per ml as described (17) and mIL-lOR-expressing cells (BaMR29a) were twice sorted and expanded in culture prior to use in experiments. Ba/F3 cells transfected with the neomycin-resistance plasmid alone (BaF-Neo) served as a negative control. Transfected cells (5000 per well) were tested for response to mIL-10 in 100-Al cultures of RPMI 1640 medium/l0o fetal calf serum/50 ,mM 2-mercaptoethanol with mIL-10 and/or 10 Mg/ml mAb for 48 hr.
Cell proliferation was measured by a colorimetric assay using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma) (17, 27) .
RESULTS
Detection of mIL-lOR-Expressing Cells. We expressed a "FLAG" (18) epitope-tagged mIL-10 that was detected by anti-FLAG mAbs. The biological activities of FLAG-mIL-10-assessed by inhibition of cytokine synthesis by an activated T-cell clone (2, 3) and costimulation of proliferation of the MC/9 mast cell line (13, 15)-were indistinguishable from wild-type mIL-10. Furthermore, anti-FLAG mAbs Ml and M2 added to bioassays in vitro did not neutralize the biological activities of FLAG-mIL-10 (data not shown).
Cells and cell lines representative of mIL-10-responsive cells were tested for ability to bind FLAG-mIL-10. A mast cell line (MC/9) and a macrophage cell line (J774) were found to give reproducible but low levels of specific FLAG-mIL-10 binding that were reduced to background by excess mIL-10 as competitor (Fig. 1A) . MC/9 cells were routinely grown in the presence of mIL-3, mIL-4, and mIL-10 to achieve optimal cell proliferation, but we found that culturing MC/9 cells in the absence of mIL-10 for -48 hr prior to assay resulted in superior signals in FACS analysis. This observation suggested that only "unoccupied" mIL-lOR could be readily detected by this method or, alternatively, that mIL-lOR may undergo ligandinduced down-modulation on MC/9 cells. MC/9 and J774 were subjected to repeated cycles of sorting and selection of the 3-5% most brightly staining cells (28, 29) . Sublines MC/9-b2 (three cycles) and J774-al (two cycles) expressing a significantly higher number of receptors were obtained (Fig. 1B) and cDNA libraries were prepared from these cells.
Expression of mIL-lOR cDNA Clones. Two -3.6-kb cDNA clones, pM3.14 and pJ18, were isolated from the MC/9-b2 and J774-al libraries, respectively. COS7 cells transfected with the mIL-lOR cDNAs specifically bound FLAG-mIL-10 ( Fig. 1 C and D) . In contrast to MC/9 and J774 cells, use of the cross-linking reagent was not required for detection of mIL-lOR expressed on COS7 cells, probably because of increased avidity for ligand due to higher IL-10R density. hIL-10 also competed effectively with FLAG-mIL-10 for binding to COS-mIL-lOR (not shown), consistent with hIL-10's activity on mouse cells (1) . Binding of FLAG-mIL-10 to mIL-10R-expressing COS7 cells was not inhibited by a 100-fold molar excess of mIL-2, mIL-3, mIL-4, mIL-5, mIL-6, mIL-7, mIFN-a, mIFN-y, or vIL-10 (not shown).
mIL-lOR was visualized as a 120-to 140-kDa protein by cross-linking 35S-FLAG-mIL-10 bound to mIL-lOR expressed on MC/9 and transfected COS7 cells (Fig. 2) . No such species was detected in mock-transfected COS7 cells (not shown). Subtraction of the mass of a single FLAGmIL-10 polypeptide chain (=20 kDa) gave the estimated size of mIL-lOR as =110 kDa. IL-10 is a noncovalent homodimer (1, 21) ; longer exposures revealed a much fainter -160-kDa band that we attributed to mIL-lOR cross-linked to two FLAG-mIL-10 polypeptides. mIL-lOR Is Related to IFNRs. A 700-bp EcoRI-Sma I fragment from the 5' end of pM3.14 was used as a hybridization probe to isolate another clone from the MC/9-b2 cDNA library (pMR29) that was then used for sequence analysis. pMR29 encoded an open reading frame of 576 amino acids (Fig. 3) , including a putative signal peptide sequence of 16 amino acids (34), a 222-amino acid extracellular domain, a transmembrane segment of24 amino acids (35) , and a cytoplasmic domain of314 amino acids. The calculated molecular mass ofmIL-lOR is only =63 kDa, in contrast to the observed size of -110 kDa, suggesting that, as observed with other CRs (36) , mIL-lOR may be glycosylated at one or more of the four potential sites identified (Fig. 3) . The nucleotide and predicted protein sequences of mIL-lOR were novel, having neither identity nor close primary sequence relationship to any sequences in the GenBank (Release 74), Protein Identification Resource (Release 34), and Swissprot Protein Sequence (Release 23) data bases. pM3.14 and pJ18 differed only at the 3' end, and their open reading frames were identical.
IL-10 is predicted to be in the four a-helix bundle cytokine family (37) , and most CRs for these cytokines (for example, IL-2-IL-7 and granulocyte and granulocyte/macrophage colony-stimulating factors) are in the class I group of the CR superfamily (31) . However, mIL-lOR lacks the two distinctive sequence motifs of four conserved cysteines (paired sequentially), a tryptophan in the N-terminal portion (C-Xo20-C-X-W-X22 -C-X8s.5-C, where X is any amino acid), and a nearly invariant "WSXWS" box near the C terminus of the extracellular binding domains of class I CRs (31, 38) . In contrast, the structure of mIL-lOR is most similar to class II CRs, which include IFNRs, a viral IFNR homolog, and tissue factor (30, 31) . Structurally, the extracellular portion of mIL-lOR consists oftwo homologous segments of --110 amino acids similarin size to the immunoglobulin-like ligand binding domains of the growth hormone receptor (31, 33). The first class 11 CR domain has two conserved tryptophans and the second cysteine pair of class I CRs, whereas a unique disulfide loop is formed in the second domain (31) as shown in Fig. 3 . mIL-lOR mRNA Expression. RNA blot analysis revealed an -3.6-kb mIL-lOR mRNA species (Fig. 4) Ba/F3 cells, which expressed little or no mIL-lOR (Fig. 4) . The resulting mIL-10R+ cell line BaMR29a (Fig. 5A ) was tested for ability to bind 1251-hIL-10 and respond to mIL-10. BaMR29a cells expressed about 4000 mIL-lORs and bound 17-5I-hIL-10 with a Kd of about 70 pM, a relatively high affinity among CRs (Fig. 5B) . Neither BaF-Neo nor parental Ba/F3 cells gave a proliferative response to mIL-10, but BaMR29a cells responded to mIL-10 in a dose-dependent fashion in an MTT assay ( expressed by cells from which the cDNA clone was isolated (MC/9) (Fig. 2) . mIL-lOR mRNA was expressed in all cells examined that were known to respond to mIL-10 (Fig. 4) . Moreover, mIL-10 stimulated proliferation of Ba/F3 cells expressing recombinant mIL-lOR (Fig. 5) . We are not yet certain whether the recombinant mIL-lOR is itself sufficient to transduce a signal to the cell in response to ligand binding or if additional required receptor or signaling components are provided in trans by Ba/F3 cells. However, we conclude that the mIL-lOR that we identified is a functional receptor for IL-10, because it binds the ligand specifically and can mediate transduction of a biological response to IL-10.
It was not possible to obtain accurate ligand affinity measurements for mIL-lOR using FLAG-mIL-10. However, Tan et aL (21) have detected mIL-lOR and hIL-lOR using 125I-labeled hIL-10. Recombinant mIL-lOR expressed by BaMR29a cells binds 125I4-TL-10 with a Kd of w70 pM (Fig. 5C ). Tan et al. (21) observed that the Kd for mIL-lOR on MC/9 cells is similarly in the 50-170 pM range and have obtained similar results for recombinant mIL-lOR expressed by our cDNA clone on COS7 cells (J. Tan & C.-C. Chou, personal communication). This value is likely similar to the affinity of mIL-lOR for mIL-10, since the specific activities of mIL-10 and hIL-10 on mouse cells are similar (1) , and reflects a relatively high affinity compared to other CRs (38) , which have Kd values ranging from 30pM for the high-affinity erythropoietin receptor to 120 nM for the low-affinity hIL-3 receptor.
Since the Kd for recombinant mIL-lOR and mIL-lOR on MC/9 cells are similar, it is possible that mIL-lOR encoded by the cDNA clones accounts for most or all mIL-lOR on MC/9 cells (Fig. 2) . That binding of FLAG-mIL-10 to recombinant mIL-lOR was not inhibited by excess vIL-10 is also consistent with the lack of activity of vIL-10 on MC/9 cells (15) ; moreover, we have so far been unable to detect significant levels of binding of FLAG-vIL-10 to COS-mILlOR (Y.L. and K.W.M., unpublished data). However, like the cellular cytokine, vIL-10 inhibits macrophage activation and stimulates human and mouse B cells (1) , suggesting the possible existence of additional IL-10R components on B cells and activated macrophages.
Macrophage activation by a number of stimuli, including IFN-y, is inhibited by IL-10 (1) . In this context, the observed relationship of IL-10R to IFNR suggests several possibilities.
First, in view of the demonstration of shared subunits among receptors for different cytokines (39) , it is possible that IL-10R could likewise share a second receptor chain with an IFNR. If so, IL-10 and IFN--y might compete for binding to each other's receptors, but, as noted above, neither IFN-a nor IFN-y competed for mIL-10 binding to recombinant mIL-lOR, and up to a 100-fold excess of hIL-10 did not compete for binding to hIFN-'yR on U937 cells (C.-C. Chou & C. Lunn, personal communication). However, the IL-3, IL-5, and granulocyte/macrophage colony-stimulating factor receptor system (39) shows that although a group of CRs shares a common secondary chain, each CR is only capable of binding its cognate cytokine. A second possibility is that IL-10R activation might directly antagonize the IFNR signal transduction pathway (40, 41) , possibly by interacting with one or more intracellular components. Evaluation of these possibilities awaits further characterization of the structure and signal transduction mechanisms of IL-1OR and IFNR.
